Yildiz, HasanKoc, AhmetOztas, HaydarYildiz, Deniz2024-09-182024-09-1820080019-6479https://hdl.handle.net/20.500.12483/13799In vitro experiments and limited animal studies suggest that aspirin, nonsteroidal anti-inflammatory, drug may inhibit pancreatic carcinogenesis. So far researchers have evaluated the biochemical and metabolic properties of aspirin but there has not been any experimental study performed on the anticarcinogenesis effect of aspirin on the well-known azaserine-rat model for pancreatic carcinogenesis. This study was designed to evaluate the potential anticarcinogenetic effect of aspirin.eninfo:eu-repo/semantics/closedAccessInduced ApoptosisCancer CellsFociArticle8521871902-s2.0-39749156436Q4WOS:000255050500021Q4